The controlling shareholder of Zixin Pharmaceutical received a letter of concern from the Shenzhen Stock Exchange, requesting to explain whether Sinopharm Group and its subsidiaries can effectively control Sinopharm medicinal materials


Full Data

?
UNLOCK DATA

Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login